. Author manuscript; available in PMC: 2014 Apr 18.

Published in final edited form as: Nanomedicine (Lond). 2012 Jul 26;7(11):1697–1711. doi: 10.2217/nnm.12.65

Table 3.

Clinical chemistry in the blood.

Group	n	AST (U/l)^†	ALT (U/l)^†	LDH (U/l)^†	ALP (U/l)^†
S0	3	89 ± 5	59 ± 32	361 ± 105	165 ± 35
SH	2	98 ± 17	48 ± 11	284 ± 54	195 ± 8
LL	3	125 ± 54	36 ± 1	1187 ± 231	112 ± 24
LH	3	181 ± 26	272 ± 216	1623 ± 171	104 ± 6
H0	2	96 ± 40	31 ± 3	862 ± 424	99 ± 25
HL	4	211 ± 204	46 ± 27	984 ± 247	137 ± 34
HH	1	805	114	2227	65

^†

Results are displayed as mean ± standard deviation.

Serum AST, ALT, LDH and ALP activity were measured spectrophotometrically. The first letter of each group designation indicates the dose of nanoparticles injected: saline (S), low-dose (L) or high-dose (H) superparamagnetic iron oxide. The second letter of each group designation indicates the field strength for alternating magnetic field exposure: zero (0), low (L) or high (H) field.

ALP: Alkaline phosphatase; ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; LDH: Lactate dehydrogenase.